Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Trovagene Inc (NASDAQ:TROV)

2.10
Delayed Data
As of Feb 17
 +0.05 / +2.44%
Today’s Change
1.78
Today|||52-Week Range
6.93
0.00%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Zaniboni Stephen L
Former Chief Financial Officer
Buy4/21/201671,125$3.60$256.1K-67.44%
Tennant Stanley Neal
Director
Buy12/16/201614,966$2.00$29.9K0.00%
Tennant Stanley Neal
Director
Buy12/19/201610,000$2.10$21.0K0.00%
Zaniboni Stephen L
Former Chief Financial Officer
Buy4/21/20164,514$4.39$19.8K-67.44%
Erlander Mark
Chief Scientific Officer
Buy12/14/20165,000$2.08$10.4K+1.20%
Welch William J
Chief Executive Officer
Buy12/16/20162,500$2.10$5.3K0.00%
Welch William J
Chief Executive Officer
Buy12/16/20162,250$2.09$4.7K0.00%
Erlander Mark
Chief Scientific Officer
Buy1/02/201750,000$0.00$0.00+2.44%
Erlander Mark
Chief Scientific Officer
Sale1/02/201723,968$0.00$0.00+2.44%